
1,3,6-Tri-O-galloyl-beta-D-glucose
CAS No. 18483-17-5
1,3,6-Tri-O-galloyl-beta-D-glucose( 1,3,6-Tri-O-galloylglucose | 1,3,6-Tri-O-galloyl-β-D-glucose )
Catalog No. M23839 CAS No. 18483-17-5
1,3,6-Tri-O-galloyl-beta-D-glucose is a phenolic compound in Black Walnut Kernels. It shows anti-inflammatory activity.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 262 | In Stock |
![]() ![]() |
10MG | 389 | In Stock |
![]() ![]() |
25MG | 644 | In Stock |
![]() ![]() |
50MG | 888 | In Stock |
![]() ![]() |
100MG | Get Quote | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product Name1,3,6-Tri-O-galloyl-beta-D-glucose
-
NoteResearch use only, not for human use.
-
Brief Description1,3,6-Tri-O-galloyl-beta-D-glucose is a phenolic compound in Black Walnut Kernels. It shows anti-inflammatory activity.
-
Description1,3,6-Tri-O-galloyl-beta-D-glucose is a phenolic compound in Black Walnut Kernels. It shows anti-inflammatory activity.
-
In Vitro——
-
In Vivo——
-
Synonyms1,3,6-Tri-O-galloylglucose | 1,3,6-Tri-O-galloyl-β-D-glucose
-
PathwayOthers
-
TargetOther Targets
-
Recptorinflammation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18483-17-5
-
Formula Weight636.5
-
Molecular FormulaC27H24O18
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (78.56 mM)
-
SMILESO=C(C1=CC(O)=C(O)C(O)=C1)O[C@@H]2[C@H]([C@@H](O[C@H](COC(C3=CC(O)=C(O)C(O)=C3)=O)[C@H]2O)OC(C4=CC(O)=C(O)C(O)=C4)=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Study on the anti-inflammatory active constituents of Mangifera indica L. seed kernel.Chinese Pharmaceutical Journal, 2015,50(19):1673-7.
molnova catalog



related products
-
Cbl-b-IN-1
Cbl-b-IN-1 is a potent Cbl-b inhibitor (IC50 <100 nM) with potential anticancer activity for the study of intestinal inflammation.
-
Octahydroaminoacridi...
Octahydroaminoacridine succinate, an acetylcholinesterase inhibitor, is used potentially for the treatment of Alzheimer's disease.
-
Compound V007-6018
Compound V007-6018 is a pharmaceutical compound used for drug screening.